ATL1102 - Antisense Therap, Ionis
https://www.mdaconference.org/abstract-library/atl1102-treatment-of-non-ambulant-boys-with-dmd-stabilizes-function-modifying-plasma-proteins-with-roles-in-immune-fibrosis-bone-growth-physiology/
 
George Tachas; PhD; Antisense Therapeutics; Robert DeLisle; Ph.D; SomaLogic Inc; Christopher Mueller; Boulder Bioconsulting Inc; Ian Woodcock; MD; The Murdoch Children’s Research Institute; Australia; Advait Padhye; Mr; Antisense Therapeutics
 
Feb 16, 2024
 
Next